Literature DB >> 24022159

Programming CMV for vaccine vector design.

Srinika Ranasinghe1, Bruce D Walker.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 24022159     DOI： 10.1038/nbt.2688

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  11 in total

1.  Dual HLA class I and class II restricted recognition of alloreactive T lymphocytes mediated by a single T cell receptor complex.

Authors:  M H Heemskerk; R A de Paus; E G Lurvink; F Koning; A Mulder; R Willemze; J J van Rood; J H Falkenburg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-29       Impact factor: 11.205

2.  Cross-recognition of HLA DR4 alloantigen by virus-specific CD8+ T cells: a new paradigm for self-/nonself-recognition.

Authors:  Michael Rist; Corey Smith; Melissa J Bell; Scott R Burrows; Rajiv Khanna
Journal:  Blood       Date:  2009-07-17       Impact factor: 22.113

3.  AIDS research. More woes for struggling HIV vaccine field.

Authors:  Jon Cohen
Journal:  Science       Date:  2013-05-10       Impact factor: 47.728

Review 4.  New paradigms for HIV/AIDS vaccine development.

Authors:  Louis J Picker; Scott G Hansen; Jeffrey D Lifson
Journal:  Annu Rev Med       Date:  2011-09-19       Impact factor: 13.739

5.  Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge.

Authors:  Scott G Hansen; Cassandra Vieville; Nathan Whizin; Lia Coyne-Johnson; Don C Siess; Derek D Drummond; Alfred W Legasse; Michael K Axthelm; Kelli Oswald; Charles M Trubey; Michael Piatak; Jeffrey D Lifson; Jay A Nelson; Michael A Jarvis; Louis J Picker
Journal:  Nat Med       Date:  2009-02-15       Impact factor: 53.440

6.  Cytomegalovirus vectors violate CD8+ T cell epitope recognition paradigms.

Authors:  Scott G Hansen; Jonah B Sacha; Colette M Hughes; Julia C Ford; Benjamin J Burwitz; Isabel Scholz; Roxanne M Gilbride; Matthew S Lewis; Awbrey N Gilliam; Abigail B Ventura; Daniel Malouli; Guangwu Xu; Rebecca Richards; Nathan Whizin; Jason S Reed; Katherine B Hammond; Miranda Fischer; John M Turner; Alfred W Legasse; Michael K Axthelm; Paul T Edlefsen; Jay A Nelson; Jeffrey D Lifson; Klaus Früh; Louis J Picker
Journal:  Science       Date:  2013-05-24       Impact factor: 47.728

7.  Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.

Authors:  Supachai Rerks-Ngarm; Punnee Pitisuttithum; Sorachai Nitayaphan; Jaranit Kaewkungwal; Joseph Chiu; Robert Paris; Nakorn Premsri; Chawetsan Namwat; Mark de Souza; Elizabeth Adams; Michael Benenson; Sanjay Gurunathan; Jim Tartaglia; John G McNeil; Donald P Francis; Donald Stablein; Deborah L Birx; Supamit Chunsuttiwat; Chirasak Khamboonruang; Prasert Thongcharoen; Merlin L Robb; Nelson L Michael; Prayura Kunasol; Jerome H Kim
Journal:  N Engl J Med       Date:  2009-10-20       Impact factor: 91.245

8.  Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine.

Authors:  Scott G Hansen; Julia C Ford; Matthew S Lewis; Abigail B Ventura; Colette M Hughes; Lia Coyne-Johnson; Nathan Whizin; Kelli Oswald; Rebecca Shoemaker; Tonya Swanson; Alfred W Legasse; Maria J Chiuchiolo; Christopher L Parks; Michael K Axthelm; Jay A Nelson; Michael A Jarvis; Michael Piatak; Jeffrey D Lifson; Louis J Picker
Journal:  Nature       Date:  2011-05-11       Impact factor: 49.962

9.  Association of HLA-DRB1-restricted CD4⁺ T cell responses with HIV immune control.

Authors:  Srinika Ranasinghe; Sam Cutler; Isaiah Davis; Richard Lu; Damien Z Soghoian; Ying Qi; John Sidney; Gregory Kranias; Michael D Flanders; Madelene Lindqvist; Bjorn Kuhl; Galit Alter; Steven G Deeks; Bruce D Walker; Xiaojiang Gao; Alessandro Sette; Mary Carrington; Hendrik Streeck
Journal:  Nat Med       Date:  2013-06-23       Impact factor: 53.440

Review 10.  Desirability and feasibility of a vaccine against cytomegalovirus.

Authors:  Paul Griffiths; Stanley Plotkin; Edward Mocarski; Robert Pass; Mark Schleiss; Philip Krause; Stephanie Bialek
Journal:  Vaccine       Date:  2013-04-18       Impact factor: 3.641
View more
  4 in total

1.  miRNA-mediated targeting of human cytomegalovirus reveals biological host and viral targets of IE2.

Authors:  Rasmus Møller; Toni M Schwarz; Vanessa M Noriega; Maryline Panis; David Sachs; Domenico Tortorella; Benjamin R tenOever
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-16       Impact factor: 11.205

Review 2.  Transmissible Viral Vaccines.

Authors:  James J Bull; Mark W Smithson; Scott L Nuismer
Journal:  Trends Microbiol       Date:  2017-10-13       Impact factor: 17.079

3.  Antiviral CD8+ T Cells Restricted by Human Leukocyte Antigen Class II Exist during Natural HIV Infection and Exhibit Clonal Expansion.

Authors:  Srinika Ranasinghe; Pedro A Lamothe; Damien Z Soghoian; Samuel W Kazer; Michael B Cole; Alex K Shalek; Nir Yosef; R Brad Jones; Faith Donaghey; Chioma Nwonu; Priya Jani; Gina M Clayton; Frances Crawford; Janice White; Alana Montoya; Karen Power; Todd M Allen; Hendrik Streeck; Daniel E Kaufmann; Louis J Picker; John W Kappler; Bruce D Walker
Journal:  Immunity       Date:  2016-10-18       Impact factor: 31.745

4.  HLA class II-Restricted CD8+ T cells in HIV-1 Virus Controllers.

Authors:  Tinashe E Nyanhete; Alyse L Frisbee; Todd Bradley; William J Faison; Elizabeth Robins; Tamika Payne; Stephanie A Freel; Sheetal Sawant; Kent J Weinhold; Kevin Wiehe; Barton F Haynes; Guido Ferrari; Qi-Jing Li; M Anthony Moody; Georgia D Tomaras
Journal:  Sci Rep       Date:  2019-07-15       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.